GRADED METHYLATION IN THE PROMOTER AND BODY OF THE O-6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) GENE CORRELATES WITH MGMT EXPRESSION IN HUMAN GLIOMA-CELLS
Jf. Costello et al., GRADED METHYLATION IN THE PROMOTER AND BODY OF THE O-6-METHYLGUANINE DNA METHYLTRANSFERASE (MGMT) GENE CORRELATES WITH MGMT EXPRESSION IN HUMAN GLIOMA-CELLS, The Journal of biological chemistry, 269(25), 1994, pp. 17228-17237
Expression of the O-6-methylguanine DNA methyltransferase (MGMT) gene
in human glioma cell lines is strongly associated with resistance to t
he chemotherapeutic agent 1,3-bis(2-chloroethyl)-1-nitrosourea. To exa
mine the possibility that methylation of the body and promoter regions
of the MGMT gene is associated with MGMT expression in a graded, rath
er than a completely on/off fashion, the present study analyzed the me
thylation status of the MGMT gene in human glioma cell lines exhibitin
g a wide range of MGMT expression. Methylation in the body of the gene
was uniform within each cell line and correlated directly with MGMT e
xpression. The level of MGMT promoter methylation was also graded acro
ss the cell lines, at 21 of 25 CpGs tested, but correlated inversely w
ith MGMT expression. Two sites in the MGMT promoter were also much mor
e accessible to restriction enzyme digestion, and thus in a more open
chromatin conformation, in nuclei from high MGMT expressors relative t
o nuclei from cells with little or no MGMT expression. We conclude tha
t the level of methylation, in both the body and promoter of the MGMT
gene, is associated with MGMT expression in a graded fashion and may b
e important in setting the transcriptional state of the MGMT promoter
through changes in chromatin structure.